If you have been feeling unlike yourself lately, you are not imagining it, and you are not alone. Up to 68% of women going through menopause report mood-related symptoms, including low mood, irritability, anxiety, and sleep problems. For many women in Boulder, CO, and across the country, the emotional side of this transition can feel just as disruptive as the physical symptoms.
You do not have to simply push through it. Hormone therapy may help improve mood symptoms for some women, especially during perimenopause when hormonal shifts are most unpredictable. Published research supports a connection between estrogen therapy and mood regulation, though results vary from person to person.
Table of Contents
- The Hormone-Mood Connection
- What Patients Commonly Report
- Hormone Therapy Is Not a Standalone Mood Treatment
- How RMRM Evaluates Candidacy
- Frequently Asked Questions
- Book a Consultation
What You Need to Know
- Mood swings, irritability, anxiety, and low mood are common during perimenopause and menopause.
- Estrogen plays a role in brain chemicals that regulate mood, including serotonin, dopamine, and norepinephrine.
- A 2018 randomized clinical trial published in JAMA Psychiatry found that transdermal estradiol may help reduce the likelihood of developing depressive symptoms during the menopause transition.
- Hormone therapy may be most helpful during the perimenopause phase, not necessarily after menopause is complete.
- A physician-supervised, lab-guided approach can help determine whether hormone therapy is appropriate for mood-related symptoms.
The Hormone-Mood Connection
Many women notice emotional shifts well before their periods fully stop. Perimenopause, the transition phase leading up to menopause, usually begins in the mid-to-late 40s and can last anywhere from two to eight years.
What is happening in the body during this time?
During perimenopause, the ovaries gradually produce less estrogen and progesterone. Instead of a steady decline, hormone levels tend to swing up and down without warning. One week you may feel fine, and the next you may feel anxious, tearful, or on edge for no clear reason.
Beyond its role in reproductive function, estrogen also appears to influence the neurotransmitters that help regulate mood. According to research published in the National Library of Medicine, estrogen interacts with several key brain chemicals, including:
- Serotonin, which helps regulate mood and emotional balance
- Dopamine, which affects motivation and feelings of reward
- Norepinephrine, which plays a role in alertness and stress response
A closer look at the research reinforces this connection. A review published on PubMed found that estrogen influences serotonin transmission, binding, and metabolism in brain regions associated with mood regulation. When estrogen levels drop, the enzyme responsible for breaking down serotonin, known as monoamine oxidase A, may become more active. That increased activity could reduce the amount of serotonin available in the brain, which in turn may contribute to mood changes. Progesterone also plays a supporting role. It has a calming effect on the nervous system, and when progesterone levels become erratic during perimenopause, some women may feel more anxious or find it harder to wind down at the end of the day.
Why is perimenopause often worse than menopause for mood?
One thing that surprises many women is that the hormonal fluctuation itself, not just low hormone levels, may be what contributes most to mood symptoms. Because hormone levels swing so unpredictably during perimenopause, mood changes tend to be most intense during this phase. After menopause, when levels settle at a lower but more stable baseline, many women notice that their mood symptoms gradually ease.
Sleep disruption adds another layer. Hot flashes and night sweats can make it difficult to get consistent, restorative rest, and poor sleep on its own can lead to irritability and emotional sensitivity. When that sleep loss is layered on top of hormonal instability, mood changes may feel much harder to manage.
What Patients Commonly Report
So does hormone therapy actually improve mood? Published research and clinical experience both point toward a cautiously positive answer for many women, particularly those who are still in the perimenopause window.
What does the research show?
A 2018 randomized clinical trial published in JAMA Psychiatry followed 172 perimenopausal and early postmenopausal women over 12 months. Among those receiving a placebo, 32.3% developed clinically significant depressive symptoms, compared to just 17.3% of women receiving transdermal estradiol plus micronized progesterone. Notably, the mood benefits appeared to be independent from hot flash improvements, suggesting a more direct effect on emotional wellbeing.
More recently, a 2026 observational study published in the journal Menopause followed 260 women who had not previously used hormone therapy. Before starting treatment, about 62% of participants reported severe mood symptoms. After receiving systemic hormone therapy, that number dropped to roughly 25%.
What do patients experience?
Beyond the clinical data, many patients report improved mood stability, fewer emotional swings, and better sleep quality after starting personalized hormone therapy under physician supervision. Some notice changes within a few weeks, while for others the process may take two to three months. How quickly and how well someone responds depends on individual health factors, timing, and the type of therapy used.
Several factors may influence the outcome. Women in perimenopause or early menopause tend to see the most benefit, and those who also experience hot flashes and night sweats may see broader relief, since better sleep alone can meaningfully improve mood. A history of depression or premenstrual mood changes may also increase sensitivity to hormonal shifts during this transition. On the other hand, women who have experienced surgical or medically induced menopause may respond differently than those going through a natural transition, which is another reason why individualized evaluation matters.
Treatment for perimenopause mood swings may involve hormone therapy, though the approach is not one-size-fits-all. According to the National Institute of Child Health and Human Development, mood changes such as irritability or anxiety are recognized symptoms of menopause that may be linked to hormonal shifts and lifestyle factors. The benefits of hormone therapy for mood may be strongest during perimenopause, when the body is most sensitive to hormonal instability.
Hormone Therapy Is Not a Standalone Mood Treatment
While hormone replacement therapy may help with depression-related mood symptoms, it is not the same as a prescription for clinical depression. HRT has not been approved as a standalone treatment for depression. That said, some research suggests that when used alongside antidepressants, hormone therapy may enhance their effectiveness for women in perimenopause.
A 2020 EMAS position statement published on PubMed notes that menopausal hormone therapy may help improve depressive symptoms in perimenopausal women, especially those with vasomotor symptoms like hot flashes.
When should patients seek additional support?
Estrogen therapy mood support may help address a physiological contributor to mood symptoms, but it is not a substitute for mental health care when needed. If you are experiencing persistent sadness, loss of interest in daily activities, or thoughts of self-harm, those concerns deserve a conversation with your physician. In many cases, the most effective path forward may involve a combined approach that addresses both hormonal health and mental health together.
Alongside hormone therapy, lifestyle strategies can also play a meaningful role in managing mood. Regular physical activity, consistent sleep habits, balanced nutrition, and stress management practices all contribute to emotional resilience during this transition. Cognitive behavioral therapy is another option that may help some women build practical coping skills for the emotional challenges of perimenopause and menopause.
How RMRM Approaches Hormone Therapy
At Rocky Mountain Regenerative Medicine in Boulder, CO, hormone therapy starts with a comprehensive diagnostic panel that evaluates hormone levels, key biomarkers, and metabolic indicators. From there, an RMRM physician develops a personalized hormone therapy protocol based on lab findings and the patient’s health history. Because hormone therapy is not a set-it-and-forget-it approach, ongoing monitoring through follow-up labs and clinical check-ins helps ensure the plan stays aligned with how the patient feels over time.
Book a Consultation
The Thrive Women’s Health Program at RMRM is designed to support women through hormonal transitions with personalized, data-driven care. Patients interested in learning more about the benefits of hormone therapy for women can start with a comprehensive evaluation.
Ready to take the next step? Book an appointment or call 720-739-1616 to learn how personalized hormone support may help you live, look, and perform better longer.
Note: The information in this article is for educational purposes only and is not a substitute for professional medical care. Always consult a qualified healthcare provider before making any decisions about your health.
Sources
- The Menopause Society. “Hormone Therapy Use May Lead to Fewer Mood Disturbances During the Menopause Transition.” https://menopause.org/?p=6254
- Gordon JL, Rubinow DR, Eisenlohr-Moul TA, et al. “Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition.” JAMA Psychiatry. 2018;75(2):149-157. https://pmc.ncbi.nlm.nih.gov/articles/PMC5838629/
- Newhouse P, Dumas J. “Neurobiological Underpinnings of the Estrogen-Mood Relationship.” Curr Psychiatry Rev. 2012;8(3):247-256. https://pmc.ncbi.nlm.nih.gov/articles/PMC3753111/
- Amin Z, Canli T, Epperson CN. “Effect of estrogen-serotonin interactions on mood and cognition.” Behav Cogn Neurosci Rev. 2005;4(1):43-58. https://pubmed.ncbi.nlm.nih.gov/15886402/
- National Institute of Child Health and Human Development (NICHD). “What are the symptoms of menopause?” https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/symptoms
- Stute P, Spyropoulou A, Karageorgiou V, et al. “Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.” Maturitas. 2020;131:91-101. https://pubmed.ncbi.nlm.nih.gov/31740049/
- NIH Office of Research on Women’s Health. “Menopause Overview.” https://discoverwhr.nih.gov/research/menopause
